Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–45 of 45 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: To Assess Cardiovascular Function Clear all

Conditions: Heart Failure, Congestive
Interventions: PET scan; Device
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Interventions: Trillium™; Device
Lead sponsor: Innoventric LTD; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 8
States / cities: Thousand Oaks, California • Detroit, Michigan • Rochester, Minnesota + 5 more

Conditions: Heart Failure, Systolic, Heart Failure With Preserved Ejection Fraction
Interventions: Virtual Visit; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Coronary Artery Disease
Interventions: iFR, FFR; Device
Lead sponsor: Imperial College London; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 6
States / cities: Long Beach, California • Lakewood, Colorado • Atlanta, Georgia + 3 more

Conditions: Coronary Disease, Heart Diseases
Interventions: Myocardial contrast echocardiography, Dobutamine echocardiography; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: IpsiHand Therapy; Device
Lead sponsor: Neurolutions, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Santa Cruz, California • St Louis, Missouri

Conditions: Heart Failure, Cardiomyopathies
Interventions: Zinc Acetate; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Ischemia-Reperfusion Injury, Kidney Diseases
Interventions: Reparixin continuous infusion, reparixin intermittent infusion, placebo infusion; Drug · Other
Lead sponsor: Dompé Farmaceutici S.p.A; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Philadelphia, Pennsylvania

Conditions: Acute Decompensated Heart Failure
Interventions: Nesiritide, Nitroglycerin; Drug
Lead sponsor: Western University of Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Inglewood, California

Conditions: Stroke
Interventions: mRehab; Device
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Stroke, Broca's Aphasia
Interventions: Cortical Electrical Stimulation; Device
Lead sponsor: Northstar Neuroscience; Industry
Eligibility: 21 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Atrial Functional Mitral Regurgitation, Mitral Insufficiency
Interventions: Not listed
Lead sponsor: University Hospital of Cologne; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2035
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: To Assess Cardiovascular Function
Interventions: QuantaFlo HD; Device
Lead sponsor: Semler Scientific; Industry
Eligibility: 22 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Functional Mitral Regurgitation, Mitral Regurgitation, Mitral Insufficiency
Interventions: Edwards Cardioband System, Guideline Directed Medical Therapy; Device · Drug
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 24
States / cities: Los Angeles, California • Palo Alto, California • Aurora, Colorado + 18 more

Conditions: Heart Failure, Chronic Systolic Heart Failure, Renal Failure, Cardiorenal Syndrome
Interventions: Selective Cytopheretic Device; Device
Lead sponsor: Lenar Yessayan; Other
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Parkinson Disease, Autonomic Dysfunction
Interventions: Exercise Stress Test; Other
Lead sponsor: University of Miami; Other
Eligibility: 50 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Heart Disease, Ischemic Heart Disease, Coronary Artery Disease, Coronary Artery Disease (CAD)
Interventions: Cell Therapy; Other
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Acute on Chronic Systolic Congestive Heart Failure, Cardiorenal Syndrome
Interventions: Selective Cytopheretic Device; Device
Lead sponsor: SeaStar Medical; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Nonhemorrhagic Ischemic Stroke, Motor Function
Interventions: Observational study; Other
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 22
States / cities: Newport Beach, California • Englewood, Colorado • Lawrenceville, Georgia + 18 more

Conditions: B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma
Interventions: Best Practice, Cognitive Intervention, Comprehensive Geriatric Assessment, Nutritional Intervention, Physical Therapy, Questionnaire Administration; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Duarte, California • Irvine, California • Winston-Salem, North Carolina + 1 more

Conditions: Cardiovascular Diseases
Interventions: AngioDefender, Ultrasound; Device
Lead sponsor: Everist Genomics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 171 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Boulder, Colorado • Derby, Connecticut • Boston, Massachusetts + 1 more

Search by objective public record fields.

PET Scan to Determine Areas of Blood Flow and Activity in the Hearts of Patients With Heart Disease Taking Beta-Blockers

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Virtual Visits to Optimize Research Trial Offerings to HF Patients

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator Therapy

Smartphone and 3D Printing Based Home Rehabilitation System for Chronic Stroke

Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

QuantaFlo HD Clinical Validation Study

Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)

Parkinson's Autonomic Responses to Treadmill Walking

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD

Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

AngioDefender Versus Brachial Artery Ultrasound Imaging